Malignant melanoma of anal skin
Methodology & AI Transparency ⓘ
Malignant melanoma of anal skin Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Cancer, Oncology & Supportive Care practice, Malignant melanoma of anal skin (ICD-10 C43.51) is stratified through immunohistochemistry [Malignant melanoma of anal skin C43.51], pairing targeted symptom control with longitudinal Complete Blood Count in Malignant melanoma of anal skin (C43.51: (ANC, Hemoglobin, Platelets)) surveillance.
- 2 Real-world patient consensus: Federal ICD-10-CM code C43.51 categorizes Malignant melanoma of anal skin under Cancer, Oncology & Supportive Care.
- 3 Typical cash cost range: Primary evaluation for Malignant melanoma of anal skin incorporates immunohistochemistry [Malignant melanoma of anal skin C43.51] and symptom diary review.
- 4 Top reported side effects / signs: Longitudinal Malignant melanoma of anal skin monitoring tracks Pathology / Molecular in Malignant melanoma of anal skin (C43.51: Genomic Staging) toward Guideline-concordant surveillance (C43.51).
Ask our AI Specialists anything about Malignant melanoma of anal skin
What Is Malignant melanoma of anal skin?
Within Cancer, Oncology & Supportive Care practice, Malignant melanoma of anal skin (ICD-10 C43.51) is stratified through immunohistochemistry [Malignant melanoma of anal skin C43.51], pairing targeted symptom control with longitudinal Complete Blood Count in Malignant melanoma of anal skin (C43.51: (ANC, Hemoglobin, Platelets)) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Malignant melanoma of anal skin (C43.51) center on angiogenesis [Malignant melanoma of anal skin C43.51]. targeted cancer & oncology interventions aim to normalize Pathology / Molecular in Malignant melanoma of anal skin (C43.51: Genomic Staging).
Common Symptoms & Clinical Signs
- • Presentation of Malignant melanoma of anal skin (C43.51): abnormality detected early in Malignant melanoma of anal skin (C43.51: on age-appropriate screening)
- • Secondary Malignant melanoma of anal skin clinical sign: persistent painless lump, in Malignant melanoma of anal skin (C43.51: non-healing ulcer/mole change,)
- • Symptom flares in Malignant melanoma of anal skin correlating with Pathology / Molecular in Malignant melanoma of anal skin (C43.51: Genomic Staging) deviation outside Guideline-concordant surveillance (C43.51)
- • Functional cancer & oncology impact requiring immunohistochemistry [Malignant melanoma of anal skin C43.51] evaluation (C43.51)
Malignant melanoma of anal skin Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | C43.51 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Cancer, Oncology & Supportive Care | NLM Clinical Tables |
| Diagnostic / Lab Marker: Pathology / Molecular in Malignant melanoma of anal skin (C43.51: Genomic Staging) | Guideline-concordant surveillance (C43.51) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Complete Blood Count in Malignant melanoma of anal skin (C43.51: (ANC, Hemoglobin, Platelets)) | Safe hematologic reserve (C43.51) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Comprehensive Metabolic & in Malignant melanoma of anal skin (C43.51: Organ Function Panel) | Preserved renal/hepatic clearance (C43.51) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Malignant melanoma of anal skin
Treatment selection for Malignant melanoma of anal skin depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Malignant melanoma of anal skin)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Cost-effectiveness analysis of nivolumab vs. Placebo: Which Works Better for Relapsed malignant mesothelioma? From the perspective of the Chinese healthcare system, nivolumab was not as cost-effective as placebo for relapsed malignant mesothelioma. International journal of clinical pharmacy • 2024-02-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 37991664 ↗ |
| Can This Approach Help? Inside the Latest Research on Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Single-dose zoledronic acid 5 mg iv together with vitamin D may enhance resolution of bone marrow lesions over 6 weeks along with reduction of pain compared with vitamin D supplementation only. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • 2022-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 34954857 ↗ |
| New Insights on Optimizing Treatment in Intermediate-Risk Prostate Cancer: Secondary Analysis of: What a 600-Participant Study Found In IRPC, therapeutic. International journal of radiation oncology, biology, physics • 2021-11-01 • Phase III Randomized Trial | N = 600 | 87/100 | PMID 33901566 ↗ |
| New Insights on Vincristine and dexamethasone pulses in addition to maintenance therapy among: What a 384-Participant Study Found Conversely, the total prevalence of chemotherapy-induced thrombocytopenia was higher for patients in the treatment group than in the control group (88.9% vs. American journal of hematology • 2023-06-15 • Phase III Randomized Trial | N = 384 | 87/100 | PMID 36877527 ↗ |
| Can This Approach Help? Inside the Latest Research on A prognostic score for patients with malignant pleural mesothelioma (MPM) The proposed MRS is prognostic of patient outcome and it fine-tunes the prognosis of patients with pre-treated MPM alone or when used with the already established EORTC score. Lung cancer (Amsterdam, Netherlands) • 2022-07-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 35660972 ↗ |
Malignant melanoma of anal skin Patient Community & “People Like Me” Threads
Filter Malignant melanoma of anal skin community threads and patient logs by age, biological sex, dosage, and treatment duration.